Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingte Chen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Immunopharmacology|June 12, 2022
Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy responseJingbo Chen, Xingte Chen, Ting Li, et al.
Discover Oncology|November 28, 2024
Novel signature of ferroptosis-related long non-coding RNA to predict lower-grade glioma overall survivalShiji Wu, Wenxi Wu, Yaqi Zhong, et al.
Frontiers in Immunology|October 28, 2024
Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinomaHuipeng Fang, Xingte Chen, Yaqi Zhong, et al.
Frontiers in Immunology|November 17, 2022
Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancerLei Wang, Xingte Chen, Hejun Zhang, et al.
Frontiers in Immunology|September 18, 2024
Deciphering colorectal cancer radioresistance and immune microrenvironment: unraveling the role of EIF5A through single-cell RNA sequencing and machine learningYaqi Zhong, Xingte Chen, Shiji Wu, et al.
Combinatorial Chemistry & High Throughput Screening|February 7, 2022
An Unfolded Protein Response-Related mRNA Signature Predicting the Survival and Therapeutic Effect of Hepatocellular CarcinomaZhixiong Su, Lei Wang, Xingte Chen, et al.
Frontiers in Genetics|July 15, 2021
Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular CarcinomaXingte Chen, Lei Wang, Liang Hong, et al.
Scientific Reports|September 30, 2025
Immune system development-related signature predicts prognosis and sorafenib-treatment resistance of hepatocellular carcinoma by intergrating machine learning and single-cell analysesShiji Wu, Xingte Chen, Huipeng Fang, et al.
Journal of Translational Medicine|February 18, 2025
G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learningXingte Chen, Shiji Wu, Hongxin He, et al.
Journal for Immunotherapy of Cancer|November 30, 2023
Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activationHan Zhou, Lei Wang, Zhiwen Lin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Immunopharmacology|June 12, 2022
Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy responseJingbo Chen, Xingte Chen, Ting Li, et al.
Discover Oncology|November 28, 2024
Novel signature of ferroptosis-related long non-coding RNA to predict lower-grade glioma overall survivalShiji Wu, Wenxi Wu, Yaqi Zhong, et al.
Frontiers in Immunology|October 28, 2024
Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinomaHuipeng Fang, Xingte Chen, Yaqi Zhong, et al.
Frontiers in Immunology|November 17, 2022
Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancerLei Wang, Xingte Chen, Hejun Zhang, et al.
Frontiers in Immunology|September 18, 2024
Deciphering colorectal cancer radioresistance and immune microrenvironment: unraveling the role of EIF5A through single-cell RNA sequencing and machine learningYaqi Zhong, Xingte Chen, Shiji Wu, et al.
Combinatorial Chemistry & High Throughput Screening|February 7, 2022
An Unfolded Protein Response-Related mRNA Signature Predicting the Survival and Therapeutic Effect of Hepatocellular CarcinomaZhixiong Su, Lei Wang, Xingte Chen, et al.
Frontiers in Genetics|July 15, 2021
Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular CarcinomaXingte Chen, Lei Wang, Liang Hong, et al.
Scientific Reports|September 30, 2025
Immune system development-related signature predicts prognosis and sorafenib-treatment resistance of hepatocellular carcinoma by intergrating machine learning and single-cell analysesShiji Wu, Xingte Chen, Huipeng Fang, et al.
Journal of Translational Medicine|February 18, 2025
G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learningXingte Chen, Shiji Wu, Hongxin He, et al.
Journal for Immunotherapy of Cancer|November 30, 2023
Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activationHan Zhou, Lei Wang, Zhiwen Lin, et al.
Pageof 2